MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH TYPE II DIABETES MELLITUS. CLINICOECONOMICAL ISSUES OF EFFECTIVENESS


如何引用文章

全文:

详细

An advantage of heart bypass in patients with ischemic heart disease with hemodynamically significant lesion of coronary arteries from the point of view of clinical effectiveness and expenses per year of life considering the life quality is shown. When planning a treatment of ischemic heart disease in patients with diabetes mellitus one should consider the findings of clinicoeconomical analysis. According to our study, patients who had heart bypass showed the best clinical outcomes and a lesser cost of surgery and both expenses in the early postoperative period and the cost of medicamentous therapy and repeat surgery over 3 years of observation.

作者简介

M Lopatin

E Dronova

Email: dronova05@mail.ru

参考

  1. Козлов С. Г., Лякишев А. А., Лобанова Т. Е. и др. // Кардиология. - 2001. - № 9. - С. 81-86.
  2. Ardissino D., Cavallini C., Bramucci E., et al. // JAMA. 2004 - Vol. 292. - Р. 2727-2734.
  3. Chaitman B. R., Hardison R. M., Adler D., et al. // Circulation. - 2009. Dec. 22. - Vol. 120 (25). - P. 2529-2540.
  4. Cohen D. J., Bakhai A., Shi C., et al. // Circulation. 2004 - Vol. 110. - P. 508-514.
  5. Fajadet J., Morice M.C., Bode C., et al. // Circulation. - 2005. - Vol. 111. - Р. 1040-1044.
  6. Lin J., Fisher D., Szwerc M., et al. // Circulation. - 2005. - Vol. 112. - Р. 2175-2183.
  7. Malenka D.J., Leavitt B.J., Hearne M.J., et al. // Circulation. - 2005. - Vol.112. - P. 1371-1376.
  8. Sabatе M., Jimеnez-Quevedo P., Angiolillo D.J., et al. // Circulation. - 2005. - Vol. 11. - Р. 2175-2183.
  9. Stettler C., Allemann S., Egger M., et al. // Heart. - 2006. - Vol. 92. - P. 650-657.
  10. The BARI 2D Study Group. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease // N. Engl. J. Med. - 2009. - Vol. 360. - Р. 2503-2515.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Lopatin M.J., Dronova E.P., 2011

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 79562 от 27.11.2020 г.
##common.cookie##